Iron-Doped B₁₂N₁₂ Nanocages as High-Performance Nanocarriers for Fluorouracil and Nitrouracil: From DFT Predictions to In Vitro Apoptotic Validation in Breast Cancer Cells

The Tiny Delivery Problem

Imagine your body as a bustling, chaotic city. Sometimes, the city's defenses go haywire, and a group of cells starts building illegal, dangerous structures—this is cancer. To stop them, doctors send in "police cars" called chemotherapy drugs. One of the most famous police cars is a molecule called 5-fluorouracil (or FU for short). It's a tough cop that stops cancer cells from building new DNA, effectively shutting them down. But here's the problem: FU is a bit clumsy. It breaks down in the bloodstream almost instantly (in just 10 to 20 minutes), and when it does work, it often crashes into innocent bystanders (healthy cells) along the way, causing a lot of collateral damage like nausea and hair loss.

Scientists have been trying to build a better "police car" for decades. They want a delivery system that acts like a protective shield, keeping the drug safe until it reaches the bad neighborhood (the tumor), and then releasing it only there. This is where nanotechnology comes in. Think of nanotechnology as building microscopic vehicles, so small you can't see them, that can carry medicine through the body. One promising type of vehicle is a "nanocage"—a tiny, hollow ball made of atoms that can trap a drug inside. But even these cages have a flaw: sometimes the drug just slips out too easily, or the cage doesn't stick to the drug well enough to carry it. The big question for scientists has been: How do we tweak these microscopic cages so they hold the drug tight on the journey but let it go exactly when it arrives at the cancer?

The Iron-Clad Solution

In this study, a team of researchers from Tehran decided to test a specific idea: what if we put a tiny piece of iron inside these nanocages to make them better at holding onto cancer drugs? They didn't just guess; they used a powerful computer simulation (called DFT) to predict how different drugs would stick to different cages, and then they built the real thing in the lab to see if the computer was right.

The Computer Prediction
First, the team used their computers to model 25 different combinations. They took five different versions of the drug (including the standard FU and a new version called nitrouracil) and five different types of nanocages (some plain, some doped with oxygen, copper, zinc, or iron). They wanted to measure the "hug" between the drug and the cage. In science, a stronger hug means a more negative "interaction energy."

The computer simulations revealed a clear winner. The plain cages were okay, but the ones doped with iron (NC-Fe) were champions. Specifically, when they paired the iron-doped cage with the nitrouracil drug, the "hug" was incredibly strong, with an interaction energy of -63.2 kJ/mol. Even the standard FU drug held on tight to the iron cage at -59.8 kJ/mol. The computer told them that the iron atom acted like a magnet, creating a two-way street of electrons that locked the drug in place much better than the plain cages could. They also found that drugs with certain "electron-hungry" groups (like the nitro group in nitrouracil) stuck the best, while drugs with bulky, lazy groups (like propyluracil) didn't stick well at all.

The Lab Reality Check
But computers can be wrong, so the team went to the lab to prove it. They mixed the real iron-doped nanocages with the real drugs in water. They found that the computer was spot on. The iron cages grabbed onto the drugs with about 71.8% efficiency for FU and 75.5% for nitrouracil under perfect conditions (neutral pH, 30 minutes). When they plotted their lab results against the computer predictions, the numbers lined up almost perfectly, with a correlation score of 0.94. This means the computer simulation was a highly reliable crystal ball for this specific job.

The Biological Test
The final test was the most important: would this work on actual cancer cells? They used MCF-7 breast cancer cells and normal human cells to see if the new delivery system was a hero or a villain.

First, they checked if the empty iron cages were safe. They were! Even at high doses, the cages didn't hurt the cells; over 85% of the cells survived, proving the vehicle itself is biocompatible.

Next, they loaded the cages with the drugs and watched what happened to the cancer cells. The results were dramatic. The drug-loaded iron cages were much more effective than the free-floating drugs.

• The standard FU drug needed a concentration of 44.8 µM to kill half the cancer cells.
• The FU-loaded iron cage only needed 18.5 µM to do the same job—a 2.4-fold improvement.
• The nitrouracil-loaded cage was even better, needing 2.8 times less drug than the free version to kill the cancer.

The team also looked at how the cells died. They found that the nanocages didn't just smash the cells; they triggered a controlled self-destruction process called apoptosis. The cells' internal "suicide switches" (genes like Bax and p53) were flipped on, and the "survival switches" (like Bcl-2) were turned off. The ratio of the "kill" signal to the "survive" signal jumped by nearly 8 to 9.5 times compared to the free drug. This suggests the nanocages are successfully delivering the payload, letting the cells escape the cage once inside, and then forcing the cancer to shut itself down.

The Verdict
This paper suggests that iron-doped boron nitride nanocages are a highly promising, safe, and efficient way to deliver cancer drugs. By using a tiny bit of iron, the researchers created a microscopic carrier that holds the drug tightly during transport but releases it effectively inside the tumor, killing cancer cells much more efficiently than the drug alone. While the study was done in a lab dish and not yet in living animals, the strong match between the computer models and the lab results gives scientists a solid roadmap for building the next generation of targeted cancer therapies.